These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31742611)

  • 21. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections.
    Lodise TP; Bonine NG; Ye JM; Folse HJ; Gillard P
    BMC Infect Dis; 2019 Aug; 19(1):718. PubMed ID: 31412809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic epidemiology of third-generation cephalosporin-resistant
    Mounsey O; Marchetti L; Parada J; Alarcón LV; Aliverti F; Avison MB; Ayala CS; Ballesteros C; Best CM; Bettridge J; Buchamer A; Buldain D; Carranza A; Corti Isgro M; Demeritt D; Escobar MP; Gortari Castillo L; Jaureguiberry M; Lucas MF; Madoz LV; Marconi MJ; Moiso N; Nievas HD; Ramirez Montes De Oca MA; Reding C; Reyher KK; Vass L; Williams S; Giraudo J; De La Sota RL; Mestorino N; Moredo FA; Pellegrino M
    Appl Environ Microbiol; 2024 Mar; 90(3):e0179123. PubMed ID: 38334306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?
    Livermore DM; Hope R; Reynolds R; Blackburn R; Johnson AP; Woodford N
    J Antimicrob Chemother; 2013 Nov; 68(11):2667-74. PubMed ID: 23766490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features.
    Courpon-Claudinon A; Lefort A; Panhard X; Clermont O; Dornic Q; Fantin B; Mentré F; Wolff M; Denamur E; Branger C;
    Clin Microbiol Infect; 2011 Apr; 17(4):557-65. PubMed ID: 20649802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between the rate of third generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae and antibiotic consumption based on 143 Chinese tertiary hospitals data in 2014.
    Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
    Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1495-1502. PubMed ID: 32221726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the βLacta test, a rapid test detecting resistance to third-generation cephalosporins in clinical strains of Enterobacteriaceae.
    Renvoisé A; Decré D; Amarsy-Guerle R; Huang TD; Jost C; Podglajen I; Raskine L; Genel N; Bogaerts P; Jarlier V; Arlet G
    J Clin Microbiol; 2013 Dec; 51(12):4012-7. PubMed ID: 24068012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections: a prospective cohort study in Suva, Fiji.
    Loftus MJ; Young-Sharma TEMW; Lee SJ; Wati S; Badoordeen GZ; Blakeway LV; Byers SMH; Cheng AC; Cooper BS; Cottingham H; Jenney AWJ; Hawkey J; Macesic N; Naidu R; Prasad A; Prasad V; Tudravu L; Vakatawa T; van Gorp E; Wisniewski JA; Rafai E; Peleg AY; Stewardson AJ
    J Glob Antimicrob Resist; 2022 Sep; 30():286-293. PubMed ID: 35738385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of and Risk Factors for Third-Generation Cephalosporin-Resistant
    Cheng J; Liu Y; Li S; Pu K; Yang L; Tan L
    Infect Drug Resist; 2024; 17():543-550. PubMed ID: 38352624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individual and population level costs and health-related quality of life outcomes of third-generation cephalosporin resistant bloodstream infection in Blantyre, Malawi.
    Lester R; Mango J; Mallewa J; Jewell CP; Lalloo DA; Feasey NA; Maheswaran H
    PLOS Glob Public Health; 2023; 3(6):e0001589. PubMed ID: 37347746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ESBL Detection: Comparison of a Commercially Available Chromogenic Test for Third Generation Cephalosporine Resistance and Automated Susceptibility Testing in Enterobactericeae.
    El-Jade MR; Parcina M; Schmithausen RM; Stein C; Meilaender A; Hoerauf A; Molitor E; Bekeredjian-Ding I
    PLoS One; 2016; 11(8):e0160203. PubMed ID: 27494134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the administration of a third-generation cephalosporin (3GC) to one-day-old chicks on the persistence of 3GC-resistant Escherichia coli in intestinal flora: An in vivo experiment.
    Baron S; Jouy E; Touzain F; Bougeard S; Larvor E; de Boisseson C; Amelot M; Keita A; Kempf I
    Vet Microbiol; 2016 Mar; 185():29-33. PubMed ID: 26931388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is There an Association Between Use of Amoxicillin-Clavulanate and Resistance to Third-Generation Cephalosporins in Klebsiella pneumoniae and Escherichia coli at the Hospital Level?
    Marquet A; Vibet MA; Caillon J; Javaudin F; Chapelet G; Montassier E; Batard E
    Microb Drug Resist; 2018 Sep; 24(7):987-994. PubMed ID: 29489447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic review.
    Leopold SJ; van Leth F; Tarekegn H; Schultsz C
    J Antimicrob Chemother; 2014 Sep; 69(9):2337-53. PubMed ID: 24879668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome analysis of third-generation cephalosporin-resistant Escherichia coli and Salmonella species recovered from healthy and diseased food-producing animals in Europe.
    Sauget M; Atchon AK; Valot B; Garch FE; Jong A; Moyaert H; Hocquet D;
    PLoS One; 2023; 18(10):e0289829. PubMed ID: 37883425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of ESBL/AmpC genes and specific clones among the third-generation cephalosporin-resistant Enterobacteriaceae from canine and feline clinical specimens in Japan.
    Maeyama Y; Taniguchi Y; Hayashi W; Ohsaki Y; Osaka S; Koide S; Tamai K; Nagano Y; Arakawa Y; Nagano N
    Vet Microbiol; 2018 Mar; 216():183-189. PubMed ID: 29519514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008.
    Meyer E; Schwab F; Schroeren-Boersch B; Gastmeier P
    Crit Care; 2010; 14(3):R113. PubMed ID: 20546564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of third generation cephalosporin resistant Enterobacteriaceae from retail meats and detection of extended spectrum beta-lactamase activity.
    Rao M; Laidlaw A; Li L; Young K; Tamber S
    J Microbiol Methods; 2021 Oct; 189():106314. PubMed ID: 34461553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it.
    de Lastours V; Laouénan C; Royer G; Carbonnelle E; Lepeule R; Esposito-Farèse M; Clermont O; Duval X; Fantin B; Mentré F; Decousser JW; Denamur E; Lefort A
    J Antimicrob Chemother; 2020 Aug; 75(8):2334-2343. PubMed ID: 32417924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Epidemiology of Third-Generation-Cephalosporin-Resistant
    Stewart AG; Price EP; Schabacker K; Birikmen M; Harris PNA; Choong K; Subedi S; Sarovich DS
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33781999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27.
    Harris PNA; Ben Zakour NL; Roberts LW; Wailan AM; Zowawi HM; Tambyah PA; Lye DC; Jureen R; Lee TH; Yin M; Izharuddin E; Looke D; Runnegar N; Rogers B; Bhally H; Crowe A; Schembri MA; Beatson SA; Paterson DL;
    J Antimicrob Chemother; 2018 Mar; 73(3):634-642. PubMed ID: 29253152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.